Picture of Orion Oyj logo

ORNBV Orion Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Orion Q1 Sales Up At EUR 354.6 Million

April 23 (Reuters) - Orion Oyj ORNBV.HE:

Q1 SALES EUR 354.6 MILLION VERSUS. ESTIMATE EUR 342.9 MILLION

Q1 EBITDA EUR 91.5 MILLION

Q1 OPERATING PROFIT EUR 77.9 MILLION VERSUS. ESTIMATE EUR 70.6 MILLION

Q1 BASIC EPS EUR 0.44

Q1 NET INCOME EUR 61.3 MILLION

Q1 PRETAX PROFIT EUR 76.8 MILLION

OUTLOOK 2025: NET SALES ARE ESTIMATED TO BE EUR 1,550 MILLION TO EUR 1,650 MILLION

NUBEQA® CONTINUED TO DRIVE GROWTH OF GROUP AND INNOVATIVE MEDICINES BUSINESS DIVISION

OUTLOOK 2025: OPERATING PROFIT IS ESTIMATED TO BE EUR 350 MILLION TO EUR 450 MILLION

BOTH ROYALTY INCOME AND PRODUCT SALES INCREASED SIGNIFICANTLY FROM COMPARISON PERIOD

NUBEQA®'S PRODUCT SALES GREW FROM PREVIOUS QUARTER AND WERE AT AN ALL-TIME HIGH SO FAR

US IMPORT TARIFFS CONTINUE TO BE A HOT TOPIC WORLDWIDE, AND THERE IS A LOT OF UNCERTAINTY AROUND TOPIC RIGHT NOW

Source text: ID:nGNE8xDRDc

Further company coverage: ORNBV.HE

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))

Recent news on Orion Oyj

See all news